| Eye colour: portals into pigmentation genes and ancestry Trends in Genetics, Volume 20, Issue 8, 1 August 2004, Pages 327-332 Richard A. Sturm and Tony N. Frudakis Abstract Several recent papers have tried to address the genetic determination of eye colour via microsatellite linkage, testing of pigmentation candidate gene polymorphisms and the genome wide analysis of SNP markers that are informative for ancestry. These studies show that the gene on chromosome 15 is the major determinant of brown and/or blue eye colour but also indicate that other loci will be involved in the broad range of hues seen in this trait in Europeans. Abstract | Full Text | PDF (243 kb) |
| Genotype-Specific Recurrence Risks as Indicators of the Genetic Architecture of Complex Diseases The American Journal of Human Genetics, Volume 83, Issue 1, 11 July 2008, Pages 120-126 Montgomery Slatkin Abstract A statistic is introduced that relates discoveries made in genome-wide association (GWA) studies to patterns of disease risks among relatives. The genotype-specific recurrence risk (GSR) is the genotype-specific risk to relatives of known relationship to affected probands. The GSRs can be used for three purposes. (1) They can provide an independent test of whether an allele identified in a GWA study is associated with the disease. (2) They can provide a test of whether interactions among loci affecting the disease are multiplicative. (3) They can be used by genetic counselors to incorporate information from GWA studies for predicting the risk to relatives of known genotype. Under a multiplicative model of disease causation, the GSRs for a locus are the genotypic risks in probands for that locus multiplied by , where is Risch's recurrence risk ratio and is the contribution to from the locus of interest. If there is saturation of risk with increasing numbers of causative alleles, then observed GSRs for individuals with high-risk genotypes will be lower than predicted by the multiplicative model. Abstract | Full Text | PDF (596 kb) |
| A Three–Single-Nucleotide Polymorphism Haplotype in Intron 1 of OCA2 Explains Most Human Eye-Color Variation The American Journal of Human Genetics, Volume 80, Issue 2, 1 February 2007, Pages 241-252 David L. Duffy, Grant W. Montgomery, Wei Chen, Zhen Zhen Zhao, Lien Le, Michael R. James, Nicholas K. Hayward, Nicholas G. Martin and Richard A. Sturm Abstract We have previously shown that a quantitative-trait locus linked to the region of 15q accounts for 74% of variation in human eye color. We conducted additional genotyping to clarify the role of the locus in the inheritance of eye color and other pigmentary traits associated with skin-cancer risk in white populations. Fifty-eight synonymous and nonsynonymous exonic single-nucleotide polymorphisms (SNPs) and tagging SNPs were typed in a collection of 3,839 adolescent twins, their siblings, and their parents. The highest association for blue/nonblue eye color was found with three SNPs: T/C, G/T, and T/C ( values of 1.02×10, 1.57×10, and 4.45×10, respectively) in intron 1. These three SNPs are in one major haplotype block, with TGT representing 78.4% of alleles. The TGT/TGT diplotype found in 62.2% of samples was the major genotype seen to modify eye color, with a frequency of 0.905 in blue or green compared with only 0.095 in brown eye color. This genotype was also at highest frequency in subjects with light brown hair and was more frequent in fair and medium skin types, consistent with the TGT haplotype acting as a recessive modifier of lighter pigmentary phenotypes. Homozygotes for C/C were predominantly without freckles and had lower mole counts. The minor population impact of the nonsynonymous coding-region polymorphisms Arg305Trp and Arg419Gln associated with nonblue eyes and the tight linkage of the major TGT haplotype within the intron 1 of with blue eye color and lighter hair and skin tones suggest that differences within the 5′ proximal regulatory control region of the gene alter expression or messenger RNA–transcript levels and may be responsible for these associations. Abstract | Full Text | PDF (2946 kb) |
Copyright © 2008 The American Society of Human Genetics. All rights reserved.
The American Journal of Human Genetics, Volume 82, Issue 2, 411-423, 25 January 2008
doi:10.1016/j.ajhg.2007.10.003
Article
Manfred Kayser1,
,
, Fan Liu2, A. Cecile J.W. Janssens3, Fernando Rivadeneira4, 5, Oscar Lao1, Kate van Duijn1, Mark Vermeulen1, 8, Pascal Arp4, Mila M. Jhamai4, Wilfred F.J. van IJcken6, Johan T. den Dunnen9, Simon Heath10, Diana Zelenika10, Dominiek D.G. Despriet5, 7, Caroline C.W. Klaver5, 7, Johannes R. Vingerling5, 7, Paulus T.V.M. de Jong5, 11, 12, Albert Hofman5, Yurii S. Aulchenko2, Andre G. Uitterlinden4, 5, Ben A. Oostra2 and Cornelia M. van Duijn2
1 Department of Forensic Molecular Biology, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands
2 Genetic Epidemiology Unit of the Departments of Epidemiology & Biostatistics and Clinical Genetics, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands
3 Department of Public Health, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands
4 Genetic Laboratory of the Department of Internal Medicine, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands
5 Department of Epidemiology & Biostatistics, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands
6 Erasmus Center for Biomics, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands
7 Department of Ophthalmology, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands
8 Department of Biology, Netherlands Forensic Institute, 2490 AA Den Haag, The Netherlands
9 Leiden Genome Technology Center, Department of Human and Clinical Genetics, Leiden University Medical Center, 2300 RC Leiden, The Netherlands
10 Centre National de Genotypage, 91057 Evry Cedex, France
11 Netherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and Sciences, 1105 BA Amsterdam, The Netherlands
12 Department of Ophthalmology, Academic Medical Center, University of Amsterdam, 1100 DD Amsterdam, The Netherlands
Corresponding authorHuman iris color was one of the first traits for which Mendelian segregation was established. To date, the genetics of iris color is still not fully understood and is of interest, particularly in view of forensic applications. In three independent genome-wide association (GWA) studies of a total of 1406 persons and a genome-wide linkage study of 1292 relatives, all from the Netherlands, we found that the 15q13.1 region is the predominant region involved in human iris color. There were no other regions showing consistent genome-wide evidence for association and linkage to iris color. Single nucleotide polymorphisms (SNPs) in the HERC2 gene and, to a lesser extent, in the neighboring OCA2 gene were independently associated to iris color variation. OCA2 has been implicated in iris color previously. A replication study within two populations confirmed that the HERC2 gene is a new and significant determinant of human iris color variation, in addition to OCA2. Furthermore, HERC2 rs916977 showed a clinal allele distribution across 23 European populations, which was significantly correlated to iris color variation. We suggest that genetic variants regulating expression of the OCA2 gene exist in the HERC2 gene or, alternatively, within the 11.7 kb of sequence between OCA2 and HERC2, and that most iris color variation in Europeans is explained by those two genes. Testing markers in the HERC2-OCA2 region may be useful in forensic applications to predict eye color phenotypes of unknown persons of European genetic origin.